Keyphrases
Cellular Entry
100%
Tumor-associated
100%
Entry Receptor
100%
Human Herpesvirus
100%
MicroRNA-34a (miR-34a)
100%
Tumor
40%
Virus
40%
Human Cytomegalovirus
40%
Cytomegalovirus
40%
DNA Virus
40%
Human DNA
40%
Adenovirus
20%
Receptor 2
20%
Tumor Cells
20%
Diverse Groups
20%
Gene Products
20%
Malignancy
20%
DNA Sequencing
20%
Herpes Simplex Virus
20%
Oncogenesis
20%
CD46
20%
Tropism
20%
Transcriptional Repressor
20%
Herpes Simplex Virus 2 (HSV-2)
20%
Epstein-Barr Virus
20%
Tumor Progression
20%
Brain Tumor
20%
Tumor Protein p53 (TP53)
20%
Virus Entry
20%
Platelet-derived Growth Factor Receptor (PDGFR)
20%
DNA Gene
20%
Result Prediction
20%
Tumor Specimens
20%
Human Herpesvirus 6 (HHV-6)
20%
In Silico Prediction
20%
Complement Components
20%
Tumor Initiation
20%
Surface Molecules
20%
Non-tumor Tissue
20%
Host Genetic Background
20%
Tumor Origin
20%
Medicine and Dentistry
Neoplasm
100%
Receptor
100%
Protein P53
100%
Herpes Simplex Virus
100%
microRNA 34a
100%
Cancer
40%
Human Cytomegalovirus
40%
Virus DNA
40%
Cytomegalovirus
40%
Virus
40%
Infection
20%
Tumor Cell
20%
Carcinogenesis
20%
DNA Sequence
20%
Mediator
20%
Herpes Simplex Virus 2
20%
Human Alphaherpesvirus 1
20%
Gene Product
20%
Epstein Barr Virus
20%
Tumor Progression
20%
Adenoviridae
20%
Virus Entry
20%
In Silico
20%
Intracranial Tumor
20%
Tumor Initiation
20%
Transcriptional Activator
20%
Genetic Background
20%
Human Herpesvirus 6
20%
Membrane Cofactor Protein
20%
Complement
20%
Platelet Derived Growth Factor Alpha Receptor
20%
Immunology and Microbiology
P53
100%
Herpes Simplex Virus
100%
Human Cytomegalovirus
50%
Cytomegalovirus
50%
DNA Virus
50%
Virus
50%
Mediator
25%
Tumor Cell
25%
DNA Sequence
25%
Gene Product
25%
Viral Entry
25%
CD46
25%
Human Alphaherpesvirus 1
25%
Adenoviridae
25%
Herpes Simplex Virus 2
25%
Transcriptional Activator
25%
Complement
25%
Genetic Background
25%
Human Herpesvirus 6
25%
Platelet Derived Growth Factor Alpha Receptor
25%
Epstein Barr Virus
25%
Neuroscience
Herpes Simplex Virus
100%
P53
100%
microRNA 34a
100%
Receptor
100%
DNA Virus
40%
Cytomegalovirus
40%
Human Cytomegalovirus
40%
Carcinogenesis
20%
Gene Product
20%
DNA Sequencing
20%
Adenoviridae
20%
Epstein-Barr Virus
20%
CD46
20%
Human Herpesvirus 6
20%
Platelet Derived Growth Factor Alpha Receptor
20%
Complement
20%
Intracranial Tumor
20%